The Efficacy and Safety of Reconyl in Acute Cough Treatment

This is a 2-arm, prospective, randomized, double-blind, parallel, controlled, non-inferiority study comparing Reconyl at a dose of 225 mg three times daily and Reconyl Placebo three times daily for a 7-day course of therapy. Reconyl is a combination of four Indonesian herbals, Vitex trifolia folium, Zingiber officinale rhizome, Abrus precatorius folium, and Phaleria macrocarpa fructus, which have been traditionally used in treating cough and common cold. A combination of these herbals is expected to relieve cough and soothe throat, provide a promising cough treatment which has no side effects.

NCT Number	NCT07420491
Lead Sponsor	Dexa Medica Group Collaborators: PT Equilab International
Conditions	Cough
Enrollment	144 participants
Start Date	2025-06-26
Primary Completion	2025-10-03 (estimated)
Study Completion	2025-10-03 (estimated)
Updated on ClinicalTrials.gov	2026-02-19